Deerfield Management Company »

Spyglass Pharma shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Spyglass Pharma shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 550k 25.91

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Celcuity (CELC)
Centene Corporation (CNC)
Larimar Therapeutics (LRMR)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management
Vanguard Fiduciary Trust

View all funds holding Spyglass Pharma